The Effect of Xuesaitong Combined with Nifedipine Controlled-Release Tablets on Neurological Function and Blood Pressure Levels in Patients with Cerebral Infarction and Hypertension
Liu Fen
Chen Miaolin
Peng Feng
Abstract：Objective:To explore the treatment effect of using Xuesaitong combined with nifedipine controlled-release tablets on patients with cerebral infarction(CI)and hypertension,in order to guide the formulation of clinical treatment measures and promote the recovery of CI with hypertension patients.Methods:A total of 80 patients with CI and hypertension admitted to the hospital from June 2022 to June 2023 were randomly divided into the control group(conventional treatment and nifedipine controlled-release tablets,40 cases)and the observation group(additional treatment with Xuesaitong based on the control group for 4 weeks,40 cases).The treatment effects of these two groups were compared after the 4 weeks of treatment.Results:After treatment,the National Institutes of Health stroke scale(NIHSS),barthel index(BI),diastolic blood pressure(DBP),systolic blood pressure(SBP),IMT and carotid plaque area of these two groups were significantly different,the difference was statistically significant(P＜0.05);the adverse reactions between these two groups were compared,the difference was statistically significant(P＞0.05).Conclusion:The combination therapy of nifedipine controlled-release tablets and Xuesaitong could improve neurological function,lower blood pressure levels,reduce carotid plaque area,improve patients'daily living ability,and has high safety in patients with CI and hypertension.
Keywords：Cerebral infarctionhypertensionBlood blockageNifedipine controlled-release tabletsBlood pressure levelAdverse reaction
Publication Date：2025-11-10
Online Publishing Date：2025-12-02(First online date of this platform, not the publication date of the document)
Pages：3( 2631-2633 )